These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6980121)

  • 1. Behavior of soluble human 125I-labeled C3b, the third component of complement, after binding to human cells.
    Charriaut C; Barel M; Frade R
    Eur J Immunol; 1982 Apr; 12(4):289-94. PubMed ID: 6980121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis of the human C3b/C4b receptor during differentiation of the HL-60 cell line. Identification and characterization of a precursor molecule.
    Atkinson JP; Jones EA
    J Clin Invest; 1984 Nov; 74(5):1649-57. PubMed ID: 6334100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical characterization of C3b receptors isolated from human erythrocytes by immunoprecipitation.
    Gerdes J; Stein H
    Immunology; 1980 Dec; 41(4):929-36. PubMed ID: 7461716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer.
    Arnaout MA; Melamed J; Tack BF; Colten HR
    J Immunol; 1981 Oct; 127(4):1348-54. PubMed ID: 7276561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4).
    Frade R; Myones BL; Barel M; Krikorian L; Charriaut C; Ross GD
    Eur J Immunol; 1985 Dec; 15(12):1192-7. PubMed ID: 3878789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.
    Fearon DT
    J Exp Med; 1980 Jul; 152(1):20-30. PubMed ID: 6967510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement receptor expression by neoplastic and normal human cells.
    Gaither TA; Magrath IT; Berger M; Hammer CH; Novikovs L; Santaella M; Frank MM
    J Immunol; 1983 Aug; 131(2):899-905. PubMed ID: 6306108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding and catabolism of aggregated immunoglobulins containing C3b by U937 cells.
    Mehta RL; Takahashi H; Rudick RA; Knutson DW
    J Immunol; 1986 Mar; 136(5):1765-71. PubMed ID: 2936811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human complement (C3b) receptors defined by a mouse monoclonal antibody.
    Gerdes J; Naiem M; Mason DY; Stein H
    Immunology; 1982 Apr; 45(4):645-53. PubMed ID: 7068171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
    Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
    Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p65: A C3b-binding protein on murine cells that shares antigenic determinants with the human C3b receptor (CR1) and is distinct from murine C3b receptor.
    Wong WW; Fearon DT
    J Immunol; 1985 Jun; 134(6):4048-56. PubMed ID: 2580903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Native C3 does not bind to the C3b receptor (CR1) of human blood B lymphocytes or alter immunoglobulin synthesis.
    Berger M; Fleisher TA
    J Immunol; 1983 Mar; 130(3):1021-3. PubMed ID: 6600466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphoblastoid cell supernatants increase expression of C3b receptors on human polymorphonuclear leucocytes: direct binding studies with 125I-C3b.
    Berger M; Cross AS
    Immunology; 1984 Mar; 51(3):431-40. PubMed ID: 6230308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative.
    Kinoshita T; Takeda J; Hong K; Kozono H; Sakai H; Inoue K
    J Immunol; 1988 May; 140(9):3066-72. PubMed ID: 2966205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
    Gerdes J; Klatt U; Stein H
    Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of gp 140, a C3b-binding membrane component present on Raji cells: a comparison with factor H.
    Frade R; Barel M; Krikorian L; Charriaut C
    Eur J Immunol; 1984 Jun; 14(6):542-8. PubMed ID: 6234177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
    J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma.
    Yoon SH; Fearon DT
    J Immunol; 1985 May; 134(5):3332-8. PubMed ID: 3156931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative pathway of complement activation by stimulated T lymphocytes. II. Elevation of cytotoxic potential against complement receptor-carrying cell lines.
    Ramos OF; Sármay G; Eggertsen G; Nilsson B; Klein E; Gergely J
    Eur J Immunol; 1987 Jul; 17(7):975-9. PubMed ID: 3111863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.